Business Segments · Revenue
Biopharma Laboratory Services — Revenue
Labcorp Holdings Biopharma Laboratory Services — Revenue decreased by 1.6% to $780.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.2%, from $721.30M to $780.60M. Over 3 years (FY 2022 to FY 2025), Biopharma Laboratory Services — Revenue shows an upward trend with a 4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Higher revenue indicates strong market demand and successful service delivery to biopharma partners.
Detailed definition
This represents the total gross income generated by the Biopharma Laboratory Services segment from providing laboratory...
Peer comparison
Core performance metric for all service-based business segments.
Metric ID:
lh_segment_biopharma_laboratory_services_revenuesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $674.33M | $674.33M | $674.33M | $674.33M | $693.55M | $693.55M | $693.55M | $693.55M | $710.90M | $707.00M | $737.70M | $767.00M | $721.30M | $784.80M | $799.10M | $793.00M | $780.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% | +2.5% | -0.5% | +4.3% | +4.0% | -6.0% | +8.8% | +1.8% | -0.8% | -1.6% |
| YoY Change | — | — | — | — | +2.9% | +2.9% | +2.9% | +2.9% | +2.5% | +1.9% | +6.4% | +10.6% | +1.5% | +11.0% | +8.3% | +3.4% | +8.2% |
Range$674.33M – $799.10M
CAGR+3.7%
Avg YoY Growth+5.0%
Median YoY Growth+2.9%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's biopharma laboratory services — revenue?
- Labcorp Holdings (LH) reported biopharma laboratory services — revenue of $780.60M in Q1 2026.
- How has Labcorp Holdings's biopharma laboratory services — revenue changed year-over-year?
- Labcorp Holdings's biopharma laboratory services — revenue increased by 8.2% year-over-year, from $721.30M to $780.60M.
- What is the long-term trend for Labcorp Holdings's biopharma laboratory services — revenue?
- Over 3 years (2022 to 2025), Labcorp Holdings's biopharma laboratory services — revenue has grown at a 4.7% compound annual growth rate (CAGR), from $2.70B to $3.10B.
- What does biopharma laboratory services — revenue mean?
- Total sales generated by the Biopharma Laboratory Services segment.